ASX:CHM - CHIMERIC THERAPEUTICS LIMITEDAscending triangle formation is clearly visible. IMO - there is a bit of swing possible still but a good entry point if it breaks 0.345.
$0.345 has been a good resistance level for CHM and can be quite visible.
Fib levels also looking good, breaking the triangle formation, it could go upwards and o
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.013 AUD
−12.53 M AUD
0.00 AUD
817.85 M
About CHIMERIC THERAPEUTICS LIMITED
Sector
Industry
CEO
Rebecca McQualter
Website
Headquarters
Carlton
Founded
2020
ISIN
AU0000121576
FIGI
BBG00YD0SSH0
Chimeric Therapeutics Ltd. is a clinical stage cell therapy company, which engages in the development and commercialization of cell therapies in oncology. Its products include NK Cell Derived Allogenic Therapies and T Cell Derived Autologous Therapies. The company was founded by Paul A. Hopper in 2020 and is headquartered in Carlton South, Australia.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of CHM is 0.009 AUD — it has decreased by −10.00% in the past 24 hours. Watch CHIMERIC THERAPEUTICS LIMITED stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on ASX exchange CHIMERIC THERAPEUTICS LIMITED stocks are traded under the ticker CHM.
CHM stock has fallen by −10.00% compared to the previous week, the last month showed zero change in price, over the last year CHIMERIC THERAPEUTICS LIMITED has showed a −71.88% decrease.
CHM stock is 11.11% volatile and has beta coefficient of 0.89. Track CHIMERIC THERAPEUTICS LIMITED stock price on the chart and check out the list of the most volatile stocks — is CHIMERIC THERAPEUTICS LIMITED there?
Yes, you can track CHIMERIC THERAPEUTICS LIMITED financials in yearly and quarterly reports right on TradingView.
CHIMERIC THERAPEUTICS LIMITED is going to release the next earnings report on Feb 19, 2025. Keep track of upcoming events with our Earnings Calendar.
CHM net income for the last half-year is −14.97 M AUD, while the previous report showed 2.44 M AUD of net income which accounts for −712.68% change. Track more CHIMERIC THERAPEUTICS LIMITED financial stats to get the full picture.
No, CHM doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, CHM shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CHIMERIC THERAPEUTICS LIMITED stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So CHIMERIC THERAPEUTICS LIMITED technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating CHIMERIC THERAPEUTICS LIMITED stock shows the sell signal. See more of CHIMERIC THERAPEUTICS LIMITED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.